This 44,000 sq. ft. San Francisco site empowers cell therapy innovators through a strategically designed facility and robust service offering including both process and analytical development capabilities and clinical and commercial cGMP manufacturing services for autologous and allogeneic cell therapies.
Learn more about the specific equipment and capabilities at this site by downloading our Site Fact Sheet.